0000950170-24-081596.txt : 20240703
0000950170-24-081596.hdr.sgml : 20240703
20240703165652
ACCESSION NUMBER: 0000950170-24-081596
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: OPKO HEALTH, INC.
CENTRAL INDEX KEY: 0000944809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39482
FILM NUMBER: 241100757
BUSINESS ADDRESS:
STREET 1: 4400 BISCAYNE BLVD.
CITY: MIAMI
STATE: FL
ZIP: 33137
BUSINESS PHONE: 305-575-4181
MAIL ADDRESS:
STREET 1: 4400 BISCAYNE BLVD.
CITY: MIAMI
STATE: FL
ZIP: 33137
FORMER NAME:
FORMER CONFORMED NAME: Opko Health, Inc.
DATE OF NAME CHANGE: 20070621
FORMER NAME:
FORMER CONFORMED NAME: eXegenics Inc
DATE OF NAME CHANGE: 20040505
FORMER NAME:
FORMER CONFORMED NAME: EXEGENICS INC
DATE OF NAME CHANGE: 20011114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GeneDx Holdings Corp.
CENTRAL INDEX KEY: 0001818331
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 851966622
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LUDLOW STREET
STREET 2: NORTH TOWER, 8TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 617 780 8742
MAIL ADDRESS:
STREET 1: 333 LUDLOW STREET
STREET 2: NORTH TOWER, 8TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
FORMER COMPANY:
FORMER CONFORMED NAME: Sema4 Holdings Corp.
DATE OF NAME CHANGE: 20210721
FORMER COMPANY:
FORMER CONFORMED NAME: CM Life Sciences, Inc.
DATE OF NAME CHANGE: 20200715
4
1
ownership.xml
4
X0508
4
2024-07-01
0001818331
GeneDx Holdings Corp.
WGS
0000944809
OPKO HEALTH, INC.
4400 BISCAYNE BLVD.
MIAMI
FL
33137
false
false
true
false
true
Class A Common Stock
2024-07-01
4
S
false
50000
26.634
D
3508603
D
Class A Common Stock
2024-07-02
4
S
false
25000
29.1238
D
3483603
D
Class A Common Stock
2024-07-03
4
S
false
14082
28.2269
D
3469521
D
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.4607 to $26.95, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.31 to $31.20, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.965, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (3) to this Form 4.
Steven D. Rubin, Exec. VP - Administration
2024-07-03